Viewing StudyNCT04298606



Ignite Creation Date: 2024-05-06 @ 2:22 PM
Last Modification Date: 2024-10-26 @ 1:30 PM
Study NCT ID: NCT04298606
Status: RECRUITING
Last Update Posted: 2023-08-01
First Post: 2020-03-04

Brief Title: A Vaccine CIMAvax-EGF for the Prevention of Lung Cancer Development or Recurrence
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Stage IIIA Lung Cancer AJCC v8
Chronic Obstructive Pulmonary Disease
Lung Non-Small Cell Carcinoma
Pneumonia
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Keywords: